PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1532778
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1532778
Tumor Transcriptomics Market, By Product type, By Application, By Technology, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Tumor Transcriptomics Market size was valued at USD 5,790.10 Million in 2023, expanding at a CAGR of 10.10% from 2024 to 2032.
Tumor transcriptomics involves analyzing the gene expression profiles of tumors by examining RNA molecules (transcripts). This method identifies genes that are either over-expressed or under-expressed compared to healthy tissue, revealing the molecular characteristics of tumors. This approach offers insights into how tumors develop, progress, and potential targets for treatment. Tumor transcriptomics is crucial for personalized medicine as it allows for the identification of key mutations driving cancer and facilitates the customization of treatment plans based on the specific transcriptional profile of each tumor.
Tumor Transcriptomics Market- Market Dynamics
Increasing research and development in diagnostics and drug discovery to propel market demand
The growth of the transcriptomics market is being actively driven by increasing research and development in diagnostics and drug discovery, the rising prevalence of chronic diseases like cancer and neuromuscular disorders, and expanding applications of transcriptomics. Transcriptomics plays a crucial role in accelerating disease diagnostics, especially with the growing global burden of chronic diseases such as cancer and diabetes. For example, according to the GLOBOCAN 2020 report, there were approximately 19.2 million new cancer cases and 9.9 million cancer deaths worldwide. This increasing patient population is expected to positively impact market growth. The market growth is anticipated to be significantly driven by product launches, expansions, collaborations, and acquisitions from key market players. For example, in February 2020, Caris Life Sciences introduced its latest genomic profiling offering, MI Transcriptome, which utilizes Whole Transcriptome Sequencing (WTS). This technology enables detailed RNA profiling of patients' tumors, complementing Caris' comprehensive approach that assesses DNA, RNA, and proteins to tailor therapies accurately. Such launches are poised to positively impact market expansion. Similarly, in February 2020, Dovetail Genomics expanded its global reach with the availability of Dovetail HiChIP and Micro-C Kits, aiming to broaden its customer base worldwide and further stimulate market growth.
Tumor Transcriptomics Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.10% over the forecast period (2024-2032)
Based on Product type segmentation, instruments was predicted to show maximum market share in the year 2023
Based on technology segmentation, sequencing technologies was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
Tumor Transcriptomics Market- Segmentation Analysis:
The Global Tumor Transcriptomics Market is segmented on the basis of Product type, Application, Technology, and Region.
The market is divided into three categories based on Product type: Consumables, Instruments, and Other Products. In terms of product types, instruments hold a dominant position due to their critical role in conducting transcriptomic analyses. Instruments such as microarray scanners, real-time quantitative PCR machines, and next-generation sequencing platforms are essential for generating data and performing high-throughput transcriptome analysis. These instruments are pivotal for researchers and clinicians seeking to understand disease mechanisms, identify biomarkers, and develop personalized treatment strategies, thereby solidifying their dominance in the market.
The market is divided into three categories based on technology: Microarray, Real-time Quantitative Polymerase Chain Reaction (Q-PCR) and Sequencing Technologies. In the transcriptomics market, sequencing technologies dominate the technology segment due to their advanced capabilities in analyzing the transcriptome with high resolution. RNA sequencing (RNA-Seq) has revolutionized transcriptomic studies by allowing researchers to detect rare transcripts, study alternative splicing events, and quantify gene expression levels accurately. This technology's ability to provide comprehensive insights into gene expression profiles and molecular pathways has made it indispensable in both research and clinical applications, driving its dominance in the market.
Tumor Transcriptomics Market- Competitive Landscape:
Recent Developments:
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL TUMOR TRANSCRIPTOMICS MARKET, BY PRODUCT TYPE - MARKET ANALYSIS, 2019 - 2032
GLOBAL TUMOR TRANSCRIPTOMICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
GLOBAL TUMOR TRANSCRIPTOMICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
GLOBAL TUMOR TRANSCRIPTOMICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
Table of Contents
1. Tumor Transcriptomics Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Tumor Transcriptomics Market Snippet by Product type
- 2.1.2. Tumor Transcriptomics Market Snippet by Application
- 2.1.3. Tumor Transcriptomics Market Snippet by Technology
- 2.1.4. Tumor Transcriptomics Market Snippet by Country
- 2.1.5. Tumor Transcriptomics Market Snippet by Region
3. Tumor Transcriptomics Key Market Trends
4. Tumor Transcriptomics Industry Study
5. Tumor Transcriptomics Market: COVID-19 Impact Analysis
6. Tumor Transcriptomics Market Landscape
7. Tumor Transcriptomics Market - By Product type
8. Tumor Transcriptomics Market - By Application
9. Tumor Transcriptomics Market - By Technology
10. Tumor Transcriptomics Market- By Geography
11. Key Vendor Analysis- Tumor Transcriptomics Industry
12. 360 Degree Analyst View
13. Appendix
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Tumor Transcriptomics Market: Product type Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Product type
- TABLE Global Tumor Transcriptomics Market, by Product type 2019-2032 (USD Million)
- TABLE Tumor Transcriptomics Market: Application Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Application
- TABLE Global Tumor Transcriptomics Market, by Application 2019-2032 (USD Million)
- TABLE Tumor Transcriptomics Market: Technology Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Technology
- TABLE Global Tumor Transcriptomics Market, by Technology 2019-2032 (USD Million)
List of Figures
